Advertisement

Search Results for "sun-pharma"

Forbes List Logo
Daiichi could be the biggest beneficiary of the Sun Pharma-Ranbaxy deal
The acquisition could bring to an end a torrid phase for Ranbaxy
BySalil Panchal
Dilip Shanghvi has built Sun Pharma by making bold bets. And he's not done yet
ByNaini Thaker
Corporate governance lapses at Sun Pharma haunt Shanghvi
BySamar Srivastava
From Dilip Shanghvi's quiet leadership at Sun Pharma to Bhavish Aggarwal's disruption spree, our top stories of the week
ByForbes India
Sun Pharma sees 70% increase in revenues in FY15
ByShabana Hussain
Dilip Shanghvi's Sun Pharma Enters the Next Phase of Growth
BySeema Singh
Tech5: Big Tech leads US selloff, Apple reportedly planning 'dramatic' software overhaul, Sun Pharma to acquire Checkpoint, and more
ByHarichandan Arakali
How acquisitions turned out to be Sun Pharma's winning strategy
ByNaini Thaker
Fancy 'Sun' in your pocket?
ByForbes India
IMD report: Here comes the Sun
BySamidha Jain
Nothing like the sun (and wind)
BySourav Majumdar
Alkem Laboratories: From pharma distribution to a Rs 11,600 crore pharma major
ByNaini Thaker
FMCG Lessons for Pharma
ByISBInsight
...

Latest News

Photo of the day: India Art Fair kicks off in Delhi
ByForbes India
RBI likely to hold interest rates in February 6 policy meet
BySalil Panchal
Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
India’s concert economy: Booming sales, lagging infrastructure
ByNaini Thaker,Himani Kothari
AI agents form their own social network, humans left fascinated and alarmed
ByNaini Thaker
Advertisement
Advertisement

On Everyone’s Radar

Advertisement